The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.11BCNY
314.80M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
358.89MCNY
53.55M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-61.02%
Updated Sep 21, 2026
Beta
0.3200x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-25.49%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
2.11BCNY
314.80M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
2.96BCNY
441.01M · vs all stocks (USD)
Updated Sep 21, 2026
Price to Sales (TTM)
5.88x
Updated Sep 21, 2026
Price to Book (MRQ)
4.04x
Updated Sep 21, 2026
Enterprise to Revenue
8.23x
Updated Sep 21, 2026
Enterprise to EBITDA
-119.25x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 85.55×.Updated Sep 21, 2026
Gross Margin
30.48%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 28.45%.Updated Sep 21, 2026
Profit Margin
-61.02%
Updated Sep 21, 2026
Operating Margin
-22.21%
Updated Sep 21, 2026
Return on Assets (TTM)
-1.80%
Updated Sep 21, 2026
Return on Equity (TTM)
-33.73%
Updated Sep 21, 2026
Revenue (TTM)
358.89MCNY
53.55M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
2.02CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
-7.20%
Updated Sep 21, 2026
Gross Profit (TTM)
102.10MCNY
15.24M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
34.55MCNY
5.16M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-219.00MCNY
-32.68M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-7.21%
Updated Sep 21, 2026
Operating Cash Flow (TTM)
27.88MCNY
4.16M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
129.85MCNY
19.38M · vs all stocks (USD)
Updated Sep 21, 2026
Payout Ratio
0.00%
Updated Sep 21, 2026
Minority Interest (Equity)
18.54MCNYFY2025 · Dec 31, 2025
Revenue
373.70MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
269.61MCNYFY2025 · Dec 31, 2025
Gross Profit
104.10MCNYFY2025 · Dec 31, 2025
Operating Income
5.64MCNY
842.33K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-165.26MCNYFY2025 · Dec 31, 2025
Income Tax Expense
12.59MCNYFY2025 · Dec 31, 2025
Net Income
-177.85MCNYFY2025 · Dec 31, 2025
EBIT
-118.44MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
34.55MCNYFY2025 · Dec 31, 2025
Research & Development
13.86MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
17.72MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
14.04MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
24.81MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
46.82MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-1.00CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-1.00CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
178.05MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
178.05MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-177.85MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-193.62KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-174.97MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-184.24MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
3.78MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-177.85MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
49.51MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-38.29MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-8.33MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-9.26MCNYFY2025 · Dec 31, 2025
Net Acquisitions
5.92MCNYFY2025 · Dec 31, 2025
Sale of Investments
150.00KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-3.19MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
72.37MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-105.60MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-21.25MCNYFY2025 · Dec 31, 2025
Other Financing Charges
5.46MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-49.03MCNYFY2025 · Dec 31, 2025
Shares Outstanding
177.28MSharesUpdated Sep 21, 2026
Float Shares
117.72MSharesUpdated Sep 21, 2026
% Held by Insiders
37.29%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
0.53%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
63.77MCNY
9.52M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
0.3600CNYUpdated Sep 21, 2026
Total Debt (MRQ)
890.89MCNY
132.94M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
1.65x
Updated Sep 21, 2026
Current Ratio (MRQ)
0.5700x
Updated Sep 21, 2026
Book Value per Share (MRQ)
2.95CNYUpdated Sep 21, 2026
Total Assets
2.47BCNY
369.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
770.71MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.88BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.70BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
532.91MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.34BCNYFY2025 · Dec 31, 2025
Cash
80.91MCNYFY2025 · Dec 31, 2025
Cash Equivalents
730.92KCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
81.64MCNYFY2025 · Dec 31, 2025
Accounts Receivable
590.22MCNYFY2025 · Dec 31, 2025
Inventory
5.84MCNYFY2025 · Dec 31, 2025
Accounts Payable
359.75MCNYFY2025 · Dec 31, 2025
Short-term Debt
458.84MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
16.86MCNYFY2025 · Dec 31, 2025
Long-term Debt
385.13MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
55.67MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
177.28MCNYFY2025 · Dec 31, 2025
Retained Earnings
-156.95MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
598.01MCNY
89.24M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
8.55CNYUpdated Sep 21, 2026
52-Week High
18.30CNYUpdated Sep 21, 2026
52-Week Change
-25.49%
vs all stocks
Updated Sep 21, 2026
Beta
0.3200x
vs all stocks
Updated Sep 21, 2026
50-Day MA
11.58CNYUpdated Sep 21, 2026
200-Day MA
13.20CNYUpdated Sep 21, 2026
Avg 10-Day Volume
17.96MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
10.15MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-1.23CNYUpdated Sep 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.3: distress zoneCritical
Altman Z-Score: 0.30
Supply Chain
Upstream position: supplies 5 industries, depends on 2Notable
Outgoing: 5.00Incoming: 2.00
Scale
Levered free cash flow is $19.38M, above the global median of $18.73MNotable